Table of Contents

1 Introduction (Page No. - 21)

1.1 Objectives of the Study

1.2 Definition

1.3 Market Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Limitations

1.6 Stakeholders

2 Research Methodology (Page No. - 24)

2.1 Research Data

2.2 Secondary Data

2.2.1 Secondary Sources

2.3 Primary Data

2.3.1 Key Data From Primary Sources

2.4 Market Size Estimation

2.4.1 Market Size Estimation: Bottom-Up Approach

2.4.2 Market Size Estimation: Top-Down Approach

2.5 Market Breakdown and Data Triangulation

2.6 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 36)

4.1 Attractive Opportunities in the Market

4.2 Synthesized Oligos Market, By Product

4.3 Synthesized Oligos Market, By Type

4.4 Asia Pacific: Market, By Research Application and Country (2019)

4.5 Market, By therapeutic Application

4.6 Market, By End User

4.7 Geographic Snapshot: Market

5 Market Overview (Page No. - 41)

5.1 Introduction

5.2 Market Dynamics

5.2.1 Market Drivers

5.2.1.1 Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications

5.2.1.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies

5.2.1.3 Rise in Venture Capital Investments

5.2.2 Market Restraints

5.2.2.1 Price Erosion of Synthesized Oligos

5.2.2.2 Lack of A Unified Set of Regulations for therapeutic Oligos

5.2.3 Market Opportunities

5.2.3.1 Emerging Asian Markets

5.2.4 Market Challenges

5.2.4.1 Large-Scale Synthesis of Oligos

5.2.4.2 Delivery of Oligonucleotide Drugs to Specific Targets

6 Oligonucleotide Synthesis Market, By Product (Page No. - 48)

6.1 Introduction

6.2 Synthesized Oligos

6.2.1 Synthesized Oligos Market, By Product

6.2.1.1 Oligonucleotide-Based Drugs

6.2.1.1.1 Oligonucleotide-Based Drugs Dominate the Synthesized Oligos Market, By Product

6.2.1.2 Primers

6.2.1.2.1 Growing Research Activity Drives the Market for Primers

6.2.1.3 Probes

6.2.1.3.1 Probes are Designed to Detect Various Infectious Agents

6.2.1.4 Intermediate-Scale Synthesized Oligos

6.2.1.4.1 The Increasing Demand for Synthesized Oligos and Innovations in Manufacturing Techniques Drives the Market.

6.2.1.5 Large-Scale Synthesized Oligos

6.2.1.5.1 Increasing Demand for Large Quantities of Modified and Unmodified Oligos to Drive the Market

6.2.1.6 Linkers & Adaptors

6.2.1.6.1 Linkers are Used to Add Restriction Sites in Dna

6.2.2 Synthesized Oligos Market, By Type

6.2.2.1 Predesigned Oligos

6.2.2.1.1 Predesigned Oligos Dominate the Market, By Type

6.2.2.2 Custom Oligos

6.2.2.2.1 Increasing Number of Clinical and Pre-Clinical Research to Drive the Market for Custom Oligos

6.3 Reagents

6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application (Page No. - 63)

7.1 Introduction

7.2 Therapeutic Applications

7.2.1 Dna & Antisense Oligonucleotide-Based Therapies

7.2.1.1 Dna & Antisense Oligos Form the Largest Segment in the Therapeutic Applications Market

7.2.2 Rnai Oligonucleotide-Based Therapies

7.2.2.1 Significant Initiatives By Pharmaceutical and Biotechnology Companies to Drive the Market for Rnai Oligonucleotide-Based Therapies

7.2.3 Cpg Oligonucleotide-Based Therapies

7.2.3.1 This Market Segment is in the Initial Stage, and Significant Growth Might Be Observed During the Forecast Period

7.3 Diagnostic Applications

7.4 Research Applications

7.4.1 PCR

7.4.1.1 Increasing Use of PCR in Research to Drive Market Growth

7.4.2 QPCR

7.4.2.1 Its Cost-Effectiveness, Concurrent Monitoring of Expression Levels of Multiple Genetic Messages in Real Time, and High Sensitivity Make QPCR A Vital Tool for Quantification of Nucleic Acids

7.4.3 Sequencing

7.4.3.1 Advancements in Sequencing Technologies and Low Cost to Drive the Market for Sequencing Applications

7.4.4 Gene Synthesis

7.4.4.1 Increasing Applications of Gene Synthesis and Low Cost to Drive the Market for This Application Segment

7.4.5 Other Research Applications

8 Oligonucleotide Synthesis Market, By End User (Page No. - 78)

8.1 Introduction

8.2 Hospitals

8.2.1 Hospitals are the Largest End Users of Oligos Due to the Significant Number of Inpatient and Outpatient Visits

8.3 Academic Research Institutes

8.3.1 Academic Researchers Primarily Use Oligos for Genetic Engineering, PCR Activities, and High-Throughput Sequencing�A Major Factor Driving Market Growth

8.4 Pharmaceutical & Biotechnology Companies

8.4.1 Growing Applications of Oligos in Drug Discovery & therapeutics to Drive the Demand for Oligonucleotide Synthesis Among these End Users

8.5 Diagnostic Laboratories

8.5.1 Diagnostic Laboratories Register High Growth in the Market Due to the Increasing Significance of Oligos in Molecular Diagnostics

9 Oligonucleotide Synthesis Market, By Region (Page No. - 85)

9.1 Introduction

9.2 North America

9.2.1 US

9.2.1.1 Government Initiatives and Strategic Developments By Market Players to Drive Market Growth in the Country

9.2.2 Canada

9.2.2.1 Growing Initiatives and Funding in Synthetic Biology and Genomics to Drive the Market in the Country

9.3 Europe

9.3.1 Germany

9.3.1.1 Presence of A Large Number of Academic Research Institutes to Support Market Growth

9.3.2 France

9.3.2.1 Government Initiatives to Boost R&D Activities in the Country

9.3.3 UK

9.3.3.1 Growth in the Life Science Industry to Drive the Market for Oligonucleotides Synthesis in the UK

9.3.4 Italy

9.3.4.1 Increasing Research Activities to Drive the Market for Oligonucleotides Synthesis in Italy

9.3.5 Spain

9.3.5.1 Government Initiatives to Drive the Market for Oligonucleotide Synthesis

9.3.6 RoE

9.4 Asia Pacific

9.4.1 China

9.4.1.1 Government Initiatives to Strengthen the Biotechnology Industry in China

9.4.2 Japan

9.4.2.1 Increasing Awareness Through Conferences and Workshops to Drive the Market in the Country

9.4.3 India

9.4.3.1 Government Initiatives to Promote Synthetic Biology to Drive the Market in the Country

9.4.4 RoAPAC

9.5 Latin America

9.5.1 Brazil

9.5.1.1 Development in Genomics to Aid Market Growth in Brazil

9.5.2 Mexico

9.5.2.1 Increasing Awareness About Advancements in Oligonucleotides to Drive the Market

9.5.3 Rolatam

9.6 Middle East & Africa

10 Competitive Landscape (Page No. - 162)

10.1 Overview

10.2 Market Share Analysis

10.3 Competitive Scenario

10.3.1 Partnerships, Agreements, Contracts, and Collaborations

10.3.2 Product Launches, Upgrades, and Approvals

10.3.3 Expansions

10.3.4 Acquisitions

10.4 Competitive Leadership Mapping (2017)

10.4.1 Vanguards

10.4.2 Innovators

10.4.3 Dynamic Players

10.4.4 Emerging Players

10.5 Competitive Leadership Mapping for Start-Ups (2018)

10.5.1 Progressive Companies

10.5.2 Starting Blocks

10.5.3 Responsive Companies

10.5.4 Dynamic Companies

10.6 MnM Dive-Vendor Comparison Matrix for Start-Ups: Market

11 Company Profiles (Page No. - 174)

(Business Overview, Products Offered, Recent Developments, MnM View)*

11.1 Agilent Technologies

11.2 Adtbio

11.3 Bioautomation (Acquired By LGC)

11.4 Bio-Synthesis Inc.

11.5 Biogen

11.6 Eurofins Genomics

11.7 Eurogentec

11.8 GE Healthcare

11.9 Genscript

11.10 Genedesign (Part of Ajinomoto)

11.11 Integrated Dna Technologies (Acquired By Danaher Corporation)

11.12 LGC Biosearch Technologies

11.13 Merck Kgaa

11.14 Nitto Denko Avecia

11.15 Sarepta therapeutics

11.16 Thermo Fisher Scientific

11.17 Trilink Biotechnologies (Part of Maravai Lifesciences)

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 223)

12.1 Insights From Industry Experts

12.2 Discussion Guide

12.3 Knowledge Store: Marketsandmarkets� Subscription Portal

12.4 Available Customizations

12.5 Related Reports

12.6 Author Details



List of Tables (157 Tables)

Table 1 Fda-Approved Oligonucleotide-Based Therapies

Table 2 Market, By Product, 2017�2024 (USD Million)

Table 3 Synthesized Oligos Market, By Region, 2017�2024 (USD Million)

Table 4 Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 5 Late-Stage Oligonucleotide-Based Therapies

Table 6 Oligonucleotide-Based Drugs Market, By Region, 2017�2024 (USD Million)

Table 7 Primers Market, By Region, 2017�2024 (USD Million)

Table 8 Probes Market, By Region, 2017�2024 (USD Million)

Table 9 Market for Intermediate-Scale Synthesized Oligos, By Region, 2017�2024 (USD Million)

Table 10 Large-Scale Synthesized Oligos Market, By Region, 2017�2024 (USD Million)

Table 11 Linkers & Adaptors Market, By Region, 2017�2024 (USD Million)

Table 12 Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 13 Predesigned Oligos Market, By Region, 2017�2024 (USD Million)

Table 14 Custom Oligos Market, By Region, 2017�2024 (USD Million)

Table 15 Oligonucleotide Synthesis Reagents Market, By Region, 2017�2024 (USD Million)

Table 16 Oligonucleotide Synthesis Equipment Market, By Region, 2017�2024 (USD Million)

Table 17 Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 18 Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 19 Market for therapeutic Applications, By Region, 2017�2024 (USD Million)

Table 20 Antisense Oligonucleotides in Clinical Trials

Table 21 Market for Dna & Antisense Oligonucleotide-Based Therapies, By Region, 2017�2024 (USD Million)

Table 22 Market for Rnai Oligonucleotide-Based Therapies, By Region, 2017�2024 (USD Million)

Table 23 Market for Cpg Oligonucleotide-Based Therapies, By Region, 2017�2024 (USD Million)

Table 24 Market for Diagnostic Applications, By Region, 2017�2024 (USD Million)

Table 25 Market for Research Applications, By Region, 2017�2024 (USD Million)

Table 26 Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 27 Market for PCR Applications, By Region, 2017�2024 (USD Million)

Table 28 Table 29 Market for Sequencing Applications, By Region, 2017�2024 (USD Million)

Table 30 Market for Gene Synthesis Applications, By Region, 2017�2024 (USD Million)

Table 31 Oligonucleotide Synthesis Market for Other Research Applications, By Region, 2017�2024 (USD Million)

Table 32 Market, By End User, 2017�2024 (USD Million)

Table 33 Market for Hospitals, By Region, 2017�2024 (USD Million)

Table 34 Market for Academic Research Institutes, By Region, 2017�2024 (USD Million)

Table 35 Market for Pharmaceutical & Biotechnology Companies, By Region, 2017�2024 (USD Million)

Table 36 Market for Diagnostic Laboratories, By Region, 2017�2024 (USD Million)

Table 37 Market, By Region, 2017�2024 (USD Million)

Table 38 North America: Market, By Country, 2017�2024 (USD Million)

Table 39 North America: Market, By Product, 2017�2024 (USD Million)

Table 40 North America: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 41 North America: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 42 North America: Market, By Application, 2017�2024 (USD Million)

Table 43 North America: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 44 North America: Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 45 North America: Market, By End User, 2017�2024 (USD Million)

Table 46 US: Market, By Product, 2017�2024 (USD Million)

Table 47 US: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 48 US: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 49 US: Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 50 US: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 51 US: Market, By End User, 2017�2024 (USD Million)

Table 52 Canada: Market, By Product, 2017�2024 (USD Million)

Table 53 Canada: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 54 Canada: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 55 Canada: Market, By Application, 2017�2024 (USD Million)

Table 56 Canada: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 57 Canada: Market, By End User, 2017�2024 (USD Million)

Table 58 Europe: Market, By Country, 2017�2024 (USD Million)

Table 59 Europe: Market, By Product, 2017�2024 (USD Million)

Table 60 Europe: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 61 Europe: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 62 Europe: Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 63 Europe: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 64 Europe: Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 65 Europe: Market, By End User, 2017�2024 (USD Million)

Table 66 Germany: Market, By Product, 2017�2024 (USD Million)

Table 67 Germany: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 68 Germany: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 69 Germany: Market, By Application, 2017�2024 (USD Million)

Table 70 Germany: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 71 Germany: Market, By End User, 2017�2024 (USD Million)

Table 72 France: Market, By Product, 2017�2024 (USD Million)

Table 73 France: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 74 France: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 75 France: Market, By Application, 2017�2024 (USD Million)

Table 76 France: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 77 France: Market, By End User, 2017�2024 (USD Million)

Table 78 UK: Oligonucleotide Synthesis Market, By Product, 2017�2024 (USD Million)

Table 79 UK: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 80 UK: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 81 UK: Market, By Application, 2017�2024 (USD Million)

Table 82 UK: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 83 UK: Market, By End User, 2017�2024 (USD Million)

Table 84 Italy: Market, By Product, 2017�2024 (USD Million)

Table 85 Italy: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 86 Italy: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 87 Italy: Market, By Application, 2017�2024 (USD Million)

Table 88 Italy: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 89 Italy: Market, By End User, 2017�2024 (USD Million)

Table 90 Spain: Market, By Product, 2017�2024 (USD Million)

Table 91 Spain: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 92 Spain: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 93 Spain: Market, By Application, 2017�2024 (USD Million)

Table 94 Spain: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 95 Spain: Oligonucleotide Synthesis Market, By End User, 2017�2024 (USD Million)

Table 96 RoE: Market, By Product, 2017�2024 (USD Million)

Table 97 RoE: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 98 RoE: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 99 RoE: Market, By Application, 2017�2024 (USD Million)

Table 100 RoE: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 101 RoE: Market, By End User, 2017�2024 (USD Million)

Table 102 APAC: Market, By Country, 2017�2024 (USD Million)

Table 103 APAC: Market, By Product, 2017�2024 (USD Million)

Table 104 APAC: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 105 APAC: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 106 APAC: Market, By Application, 2017�2024 (USD Million)

Table 107 APAC: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 108 APAC: Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 109 APAC: Market, By End User, 2017�2024 (USD Million)

Table 110 China: Oligonucleotide Synthesis Market, By Product, 2017�2024 (USD Million)

Table 111 China: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 112 China: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 113 China: Market, By Application, 2017�2024 (USD Million)

Table 114 China: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 115 China: Market, By End User, 2017�2024 (USD Million)

Table 116 Japan: Market, By Product, 2017�2024 (USD Million)

Table 117 Japan: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 118 Japan: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 119 Japan: Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 120 Japan: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 121 Japan: Market, By End User, 2017�2024 (USD Million)

Table 122 India: Market, By Product, 2017�2024 (USD Million)

Table 123 India: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 124 India: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 125 India: Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 126 India: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 127 India: Market, By End User, 2017�2024 (USD Million)

Table 128 RoAPAC: Market, By Product, 2017�2024 (USD Million)

Table 129 RoAPAC: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 130 RoAPAC: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 131 RoAPAC: Market, By Application, 2017�2024 (USD Million)

Table 132 RoAPAC: Oligonucleotide Synthesis Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 133 RoAPAC: Market, By End User, 2017�2024 (USD Million)

Table 134 Latam: Market, By Country, 2017�2024 (USD Million)

Table 135 Latam: Market, By Product, 2017�2024 (USD Million)

Table 136 Latam: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 137 Latam: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 138 Latam: Market, By Application, 2017�2024 (USD Million)

Table 139 Latam: Market for Research Applications, By Type, 2017�2024 (USD Million)

Table 140 Latam: Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 141 Latam: Market, By End User, 2017�2024 (USD Million)

Table 142 Brazil: Market, By Product, 2017�2024 (USD Million)

Table 143 Brazil: Market, By Application, 2017�2024 (USD Million)

Table 144 Brazil: Market, By End User, 2017�2024 (USD Million)

Table 145 Mexico: Market, By Product, 2017�2024 (USD Million)

Table 146 Mexico: Market, By Application, 2017�2024 (USD Million)

Table 147 Mexico: Market, By End User, 2017�2024 (USD Million)

Table 148 Rolatam: Market, By Product, 2017�2024 (USD Million)

Table 149 Rolatam: Market, By Application, 2017�2024 (USD Million)

Table 150 Rolatam: Market, By End User, 2017�2024 (USD Million)

Table 151 MEA: Market, By Product, 2017�2024 (USD Million)

Table 152 MEA: Synthesized Oligos Market, By Product, 2017�2024 (USD Million)

Table 153 MEA: Synthesized Oligos Market, By Type, 2017�2024 (USD Million)

Table 154 MEA: Oligonucleotide Synthesis Market, By Application, 2017�2024 (USD Million)

Table 155 MEA: Table 156 MEA: Market for therapeutic Applications, By Type, 2017�2024 (USD Million)

Table 157 MEA: Market, By End User, 2017�2024 (USD Million)



List of Figures (42 Figures)

Figure 1 Research Design

Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region

Figure 3 Data Triangulation Methodology

Figure 4 Synthesized Oligos Dominates the Oligonucleotide Synthesis Market, By Product, 2019�2024 (USD Million)

Figure 5 Oligonucleotide-Based Drugs Segment to Record Highest Growth, 2019�2024 (USD Million)

Figure 6 Predesigned Oligos to Dominate the Oligonucleotide Synthesis Market

Figure 7 therapeutic Applications Hold the Largest Market Share

Figure 8 Hospitals to Grow at the Highest Cagr in the End-User Market

Figure 9 North America Held Largest Share in 2018 and to Record Highest Cagr (2019�2024)

Figure 10 Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications are Driving Market Growth

Figure 11 Oligonucleotide-Based Drugs to Dominate the Market, 2019�2024 (USD Million)

Figure 12 Predesigned Oligos to Command the Largest Share of the Oligonucleotide Synthesis Market During the Forecast Period

Figure 13 PCR Held the Largest Share of the Asia Pacific Research Applications Market in 2019

Figure 14 Dna & Antisense Oligos to Register the Highest Growth Rate During the Forecast Period

Figure 15 Hospitals Segment to Witness Highest Cagr, 2019�2024 (USD Million)

Figure 16 The US to Record the Highest Cagr During the Forecast Period

Figure 17 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges

Figure 18 Synthesized Oligos to Record Highest Cagr During the Forecast Period

Figure 19 therapeutic Applications to Offer Lucrative Growth Opportunities for Market Players During 2019�2024

Figure 20 Hospitals to Dominate the Oligonucleotide Synthesis Market During the Forecast Period

Figure 21 North America: Market Snapshot

Figure 22 Europe: Market Snapshot

Figure 23 APAC: Market Snapshot

Figure 24 Latam: Market Snapshot

Figure 25 MEA: Market Snapshot

Figure 26 Key Developments in the Oligonucleotide Synthesis Market (Jan 2016-Jan 2019)

Figure 27 Market Evolution Framework

Figure 28 Global Market Share Analysis (For Research and Diagnostics), By Key Player, 2017

Figure 29 Global Market Share Analysis (For therapeutics), By Key Player, 2017

Figure 30 MnM Dive-Vendor Comparison Matrix: Exosomes Market

Figure 31 Agilent Technologies: Company Snapshot

Figure 32 Biogen: Company Snapshot

Figure 33 Eurofins Scientific Group: Company Snapshot

Figure 34 Kaneka: Company Snapshot

Figure 35 General Electric Company (GE): Company Snapshot

Figure 36 Genscript: Company Snapshot

Figure 37 Ajinomoto: Company Snapshot

Figure 38 Danaher Corporation: Company Snapshot

Figure 39 Merck Kgaa: Company Snapshot

Figure 40 Nitto Denko Corporation: Company Snapshot

Figure 41 Sarepta therapeutics: Company Snapshot

Figure 42 Thermo Fisher Scientific: Company Snapshot